MILLENNIUM MANAGEMENT LLC - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,890,692
-15.5%
346,916
+5.3%
0.00%0.0%
Q2 2023$2,237,774
+71577.6%
329,569
-47.1%
0.00%
-50.0%
Q1 2023$3,122
-43.3%
623,091
-44.8%
0.00%
-33.3%
Q4 2022$5,508
-98.4%
1,128,702
+4676.0%
0.00%
Q3 2022$341,000
-72.4%
23,633
-71.1%
0.00%
-100.0%
Q2 2022$1,237,000
+506.4%
81,777
+548.4%
0.00%
Q4 2021$204,000
-97.6%
12,613
-95.6%
0.00%
-100.0%
Q1 2021$8,615,000
+65.6%
284,888
+171.2%
0.01%
+50.0%
Q4 2020$5,201,000
+40.6%
105,057
+9.0%
0.00%
-20.0%
Q3 2020$3,700,000
-18.2%
96,368
-8.0%
0.01%
-16.7%
Q2 2020$4,524,000
+20.1%
104,720
-27.5%
0.01%
-25.0%
Q1 2020$3,768,000
-69.0%
144,373
-62.9%
0.01%
-46.7%
Q4 2019$12,165,000
+152.6%
389,295
+110.7%
0.02%
+87.5%
Q3 2019$4,816,000
-47.7%
184,806
-54.1%
0.01%
-42.9%
Q2 2019$9,205,000
+23.0%
402,493
+41.0%
0.01%
+27.3%
Q1 2019$7,484,000
-4.9%
285,526
-26.2%
0.01%
-8.3%
Q4 2018$7,870,000
-7.4%
386,919
+20.9%
0.01%
+20.0%
Q3 2018$8,497,000319,9060.01%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders